MedTrace Logo

Development of CELIAC-Q KIDS: A Patient-Reported Outcome Measure for Pediatric Celiac Disease

NCT05548166 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-11-04

No results posted yet for this study

Summary

A multicentre, prospective observational study to develop the CELIAC-Q KIDS patient reported outcome measure for children and adolescents with celiac disease. The CELIAC- Q KIDS will contain a comprehensive set of independently functioning scales designed to measure outcomes that matter to children with celiac disease, as well as scales to measure patients experience with the gluten-free diet.

Conditions

  • Celiac Disease in Children
  • Celiac Disease
  • Patient-reported Outcome Measures

Interventions

OTHER

Interview and scale development

Interview and scale development

Sponsors & Collaborators

  • The Hospital for Sick Children

    collaborator OTHER

  • Canadian Celiac Association

    collaborator UNKNOWN

  • McMaster University

    lead OTHER

Eligibility

Min Age
4 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-26
Primary Completion
2025-12-31
Completion
2026-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05548166 on ClinicalTrials.gov